Joyce K. James

Statistics

Publications

Citations

518

H-Index

Active since

1993

Affiliations

General Atomics (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Joyce K. James is an author at General Atomics (United States) specializing in pharmacology, pharmacology of glutamate receptors, and glutamatergic signaling.

Publications per year

1993–2017

Publications

Proton HR‐MAS spectroscopy and quantitative pathologic analysis of MRI/3D‐MRSI‐targeted postsurgical prostate tissues

Mark G. Swanson, Daniel B. Vigneron, Z. Laura Tabatabai et al. · Magnetic Resonance in Medicine · 2003 · 223 citations

Medicine, Biochemistry, Oncology +17

CK‐2127107 amplifies skeletal muscle response to nerve activation in humans

Jinsy Andrews, Vipin Vijayakumar, R Stoltz et al. · Muscle & Nerve · 2017 · 68 citations · Full text

Life Sciences, Pharmacology, Physiology +17

Biphenyl-indanones: Allosteric potentiators of the metabotropic glutamate subtype 2 receptor

Céline Bonnefous, Jean‐Michel Vernier, John H. Hutchinson et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 51 citations

Life Sciences, Neuroscience, Pharmacology +14

Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: Identification and biological activity of indanone containing mGlu2 receptor potentiators

Anthony B. Pinkerton, Rowena V. Cube, John H. Hutchinson et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 49 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): Efficacy in an animal model for schizophrenia

Steven P. Govek, Céline Bonnefous, John H. Hutchinson et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 43 citations · Full text

Medicine, Neuroscience, Pharmacology +14

1–5 of 8